Fargo chemistry immunochemistry option year 2 extension
Ended Awarded Last action
- Contract number
- 36C26325N0155
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 23
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,006,452
Award facts
- Contract value 22% obligated
-
- $1,006,452.10 Current, with exercised options
- $4,631,214.38 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$132,348 | |
| Supplemental Agreement for work within scope | $5,018 | |
| Funding Only Action | $0 | |
| Original award | $1,133,782 |
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 23, awarded a modification to Roche Diagnostics Corporation on October 1, 2024, to extend the Fargo Chemistry Immunochemistry option year 2 contract. This Blanket Purchase Agreement (BPA) call, issued under a Firm Fixed Price structure, increased funding for the contractor with a ceiling value of $4.63 million and an ultimate completion date of September 30, 2025. The work will be performed at Roche Diagnostics' facility in Castleton, Indiana. No set-aside designation was applied to this procurement, indicating open competition. Roche Diagnostics Corporation, a foreign-owned diagnostic solutions manufacturer headquartered in Indianapolis, Indiana, specializes in providing in vitro diagnostics, laboratory instruments, reagents, and associated medical products to federal healthcare agencies.
This contract extension supports VISN 23's diagnostic testing capabilities through Roche's immunochemistry and chemistry analysis platforms, consistent with the contractor's extensive portfolio of laboratory diagnostic equipment and services provided across the VA system. Roche maintains a substantial federal contracting presence with multiple active Indefinite Delivery Contracts and BPAs across numerous VISNs and the Defense Health Agency, with contract values ranging from under $1,000 to multi-million-dollar awards extending through 2030. The company provides comprehensive diagnostic solutions including molecular diagnostics, clinical chemistry analysis, immunochemistry testing, histology staining services, and point-of-care testing devices, positioning it as a primary supplier of advanced diagnostic capabilities to military, veterans, and civilian healthcare systems.
Quick answers
Who was awarded contract 36C26325N0155?
36C26325N0155 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 23 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C26325N0155 worth?
The government has obligated $1,006,452 on 36C26325N0155. Its potential value, with all options, is $4,631,214.
Is contract 36C26325N0155 an order under another contract?
Yes. 36C26325N0155 is a BPA call under 36C26323A0026, a blanket purchase agreement.
Was contract 36C26325N0155 competed?
The extent of competition for 36C26325N0155 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award